Hypertrophic scar
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age = 18 2. More than 1 year after internal fixation of fracture 3. Patients with clinical diagnosis of hypertrophic scar, or patients with unclear clinical diagnosis but definite postoperative pathological diagnosis of hypertrophic scar 4. Have not undergone hypertrophic scar treatment in the past, including surgery, radiotherapy, local injection of botulinum toxin, hormone, laser treatment, etc 5. No oral antibiotics or systemic treatment with intravenous antibiotics in the past three months 6. Voluntary participation in the survey
Exclusion criteria
Exclusion criteria: 1. Age<18 2. Patients clinically diagnosed as keloid 3. Antibiotics or systemic treatment with intravenous antibiotics in the past 3 months 4. The patient is resistant and unwilling to participate in the investigation 5. No or limited legal capacity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pituitary tumor transforming gene 1, PTTG1;Tenascin C, TNC; | — |
Countries
China
Contacts
Tenth People's Hospital of Tongji University